Document is current
Any future updates will be listed below
-
Authors
Crocombe, Dominic
Ahmed, Norin
Balakrishnan, Indran
Bordea, Ekaterina
Chau, Marisa
China, Louise
Corless, Lynsey
Danquah, Victoria
Dehbi, Hakim-Moulay
Dillon, John F.
Forrest, Ewan H.
Freemantle, Nick
Gear, David Peter
Hollywood, Coral
Hunter, Rachael
Jeyapalan, Tasheeka
Kallis, Yiannis
McPherson, Stuart
Munteanu, Iulia
Portal, Jim
Richardson, Paul
Ryder, Stephen D.
Virk, Amandeep
Wright, Gavin
O’Brien, Alastair
-
Funding
Funding for this research was provided by:
National Institute for Health Research (17/67/01)
- License Information
-
More Information
Article History
Received: 18 July 2022
Accepted: 8 September 2022
First Online: 27 September 2022
Declarations
:
: Research ethical approval was granted by Research Ethics Committee (South Central – Oxford B; REC 19/SC/0311) and MHRA. Written, informed consent to participate will be obtained from all participants.
: Not applicable—no identifying images or personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials can be made by email to .
: NF has acted as a consultant for Gedeon Richter, Abbott Singapore, Galderma, ALK, AstraZeneca, Ipsen, Vertex, Sanofi, Thea, Aimmune, Novatis, Novo Nordisk, Allergan, Alliance, and MSD. No non-financial conflicts. SM has received consultancy/speakers fees from Abbvie, Allergan, BMS, Gilead, Intercept, MSD, Novo Nordisk, Norgine, Novartis, and Sequana outside the submitted work. The other authors declared that they have no competing interests.
